Development of chorea with lupus anticoagulant after interferon therapy.
Neau
J P
JP
Department of Neurology, Hôpital Jean-Bernard, CHU la Milétrie, Poitiers, France.
Guilhot
F
F
Boinot
C
C
Dumas
P
P
Tantot
A M
AM
Gil
R
R
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D002819:Chorea / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D016682:Lupus Coagulation Inhibitor / Q000032:analysis; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000209:etiology*; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D016682:Lupus Coagulation Inhibitor; D011994:Recombinant Proteins